In this regard, researchers speculated that the anti-tumor cytotoxicity of T cells infiltrated in the tumor microenvironment could be reflected by the reinvigoration status of circulating PD-1+ CD8+ T cells during anti-PD-(L)1 immunotherapy. This evidence concerns the gene CD8A and neoplasm.